Type 2 diabetes trials in China

In China 189 Also abroad 1200

189 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Where
Weifang
Age
18 years to 75 years
People
75
Run by
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
See details and how to joinNCT07496177
No phaseNot yet taking people in China
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
Where
Hanzhou
Age
18 years and over
People
7,000
Run by
The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07706010
Phase 1/2Taking people
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
Where
Beijing
Age
18 years to 65 years
People
66
Run by
Peking University First Hospital
See details and how to joinNCT07693036
Phase 4Taking people
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Where
Changchun, Changsha, Hangzhou, Harbin, Hefei, Hengyang, Huizhou, Jiaxing, Nanchang, Nanjing, Ningbo, Shanghai, Shenzhen, Wuhan, Xinxiang
Age
18 years and over
People
1,316
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07307235
No phaseTaking people
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Where
Beijing
Age
18 years to 40 years
People
240
Run by
Peking University Third Hospital
See details and how to joinNCT05947916
Phase 3Taking people
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Where
Beijing
Age
18 years and over
People
350
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT07527078
No phaseTaking people
A Preliminary Clinical Study Protocol for Evaluating the Efficacy and Safety of Pulse Electric Field Ablation Systems in Treating Adult Type 2 Diabetes Mellitus With Suboptimal Drug Control
Where
Shanghai
Age
18 years to 70 years
People
20
Run by
Shanghai East Hospital
See details and how to joinNCT07678866
No phaseTaking people
Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
Where
Chengdu
Age
18 years to 69 years
People
80
Run by
Sichuan Academy of Medical Sciences
See details and how to joinNCT07676773
Phase 4Not yet taking people in China
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Where
Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Nantong, Ningbo, Shanghai, Suqian, Suzhou, Wenzhou, Xi’an
Age
18 years and over
People
148
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07667517
No phaseTaking people
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Where
Shanghai
Age
18 years to 80 years
People
160
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT07414277
Phase 4Not yet taking people in China
Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction
Where
Shanghai
Age
19 years and over
People
476
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07621380
No phaseTaking people
Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Where
Hefei
Age
18 years and over
People
88
Run by
Anhui Medical University
See details and how to joinNCT07656805
No phaseNot yet taking people in China
Ultrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral Neuropathy(DPN): Association With a Target Gene
Where
Taiyuan
Age
20 years to 75 years
People
120
Run by
Second Hospital of Shanxi Medical University
See details and how to joinNCT07595887
Phase 3Not yet taking people in China
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Where
Guangzhou
Age
18 years to 75 years
People
296
Run by
Sun Yat-sen University
See details and how to joinNCT07635953
No phaseTaking people
Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
Where
Bengbu, Guangzhou, Haikou, Hangzhou, Hefei, Hengyang, Kunming, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Weifang, Wenzhou, Wuhan, Wuhu, Xi’an, Xuzhou, Zhengzhou, Zunyi
Age
18 years and over
People
10,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07632677
Phase 2Taking people
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
Where
Beijing, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shiyan, Tianjin, Ürümqi, Wuhan, Xi’an
Age
18 years to 75 years
People
300
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07303803
No phaseTaking people
Mobile Health and Wearable Devices for Diabetes Complication Management
Where
Changsha
Age
18 years and over
People
6,000
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07129148
Phase 4Taking people
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
Where
Beijing
Age
18 years to 78 years
People
144
Run by
Junjie Yang
See details and how to joinNCT07614230
No phaseEnrolling by invitation
A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
Where
Tianjin
Age
18 years and over
People
100,000
Run by
Novo Nordisk A/S
See details and how to joinNCT07456774
No phaseNot yet taking people in China
Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
Where
Shenzhen
Age
18 years to 60 years
People
20
Run by
Eighth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07599046
Phase 4Taking people
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Where
Nanjing
Age
18 years to 70 years
People
60
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558863
Phase 4Not yet taking people in China
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
Where
Wuhan
Age
18 years to 65 years
People
400
Run by
Huazhong University of Science and Technology
See details and how to joinNCT07555730
No phaseTaking people
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Where
Lanzhou, Shanghai, Shenyang
Age
20 years to 79 years
People
2,920
Run by
Yufan Wang
See details and how to joinNCT06821399
Phase 1Taking people
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Where
Chengdu
Age
18 years to 59 years
People
55
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07032688
Phase 2Not yet taking people in China
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
Where
Beijing
Age
18 years to 75 years
People
345
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT07387003